15574 Federal Register / Vol. 60, No. 57 / Friday, March 24, 1995 / Notices

Dated: March 16, 1995.

Margery G. Grubb,

Senior Committee Management Specialist,

NIH.

[FR Doc. 95–7229 Filed 3–23–95; 8:45 am]

BILLING CODE 4140–01–M

Office of Research on Women’s

Health; Notice of Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Advisory Committee on Research on

Women’s Health to be held April 24 and

25, 1995 in Conference Room D of the

Natcher Conference Center (Building

45), 45 Center Drive, Bethesda,

Maryland 20892. The meeting will be

held from 10 am to 5 pm on April 24

and from 8:30 am to 12 pm on April 25.

The meeting is open to the public, with

attendance limited to space available.

The purpose of the meeting will be to

familiarize the Committee members

with the operations and programs of the

Office of Research on Women’s Health,

Office of the Director, National

Institutes of Health. The agenda will

include: (1) A discussion of the

Committee’s duties and responsibilities

and (2) reports on ORWH activities and

programs.

Rosemary Torres, J.D., B.S.N., Special

Assistant to the Director, Office of

Research on Women’s Health, OD, NIH,

Building 1, Room 209, Bethesda,

Maryland 20892, 301–402–1770, 301–

402–1798 (FAX), will furnish the

meeting agenda, roster of Committee

members, and substantive program

information upon request. Individuals

who plan to attend the meeting and

need special assistance, such as sign

language interpretation or other special

accommodations, should contact Ms.

Torres in advance of the meeting.

Dated: March 17, 1995.

Margery G. Grubb,

Senior Committee Management Specialist,

NIH.

[FR Doc. 95–7228 Filed 3–23–95; 8:45 am]

BILLING CODE 4140–01–M

Public Health Service

Agency Forms Submitted to the Office

of Management and Budget for

Clearance

Each Friday the Public Health Service

(PHS) publishes a list of information

collection requests under review, in

compliance with the Paperwork

Reduction Act (44 U.S.C. Chapter 35).

To request a copy of these requests, call

the PHS Reports Clearance Office on

(202)–690–7100.

The following requests have been

submitted for review since the list was

last published on Friday, March 17.

1. Adverse Experience Reporting for

Licensed Biological Products—21 CFR

600—New—This rule enables FDA to

take actions necessary for protection of

the public health in response to reports

of adverse experience related to licensed

biological products. Respondents:

Business or other for-profit, not-forprofit institutions. Send comments to

Shannah Koss, Human Resources and

Housing Branch, New Executive Office

Building, room 10235, Washington, DC

20503.

Title

No. of

respondents

No. of

responses

per respondent

Average

burden

per response

(hrs.)

Reporting: 21

CFR 600.81 .. 91 6.09 8.96

Recordkeeping:

21 CFR

600.80 (i) ...... 91 1 37

Estimated total annual burden: 8,329 hours.

2. Alcohol and Drug Services Survey

(ADSS)—Pilot Study—New—The

Alcohol and Drug Services Survey will

gather information required in the

formulation of national drug policy

through three integrated phases: (I)

Telephone survey of 2200 treatment

facilities; (II) on-site abstraction of

client-level data; (III) client follow-up to

determine post-discharge substance

abuse, criminal activity, employment,

and other social functioning.

Respondents: Individuals or

households; Business or other for-profit;

Not-for-profit institutions; Federal

Government; State, Local or Tribal

Government. Send comments to

Shannah Koss, Human Resources and

Housing Branch, New Executive Office

Building, room 10235, Washington, DC

20503.

Title

No. of

respondents

No. of

responses

per respondent

Average

burden

per response

(hrs.)

Facilities ........... 2040 1.037 0.222

Clients .............. 170 1.94 1.0

Estimated total Annual burden: 800 hours.

3. American Stop Smoking

Intervention Study for Cancer

Prevention (ASSIST) Interim

Evaluation: 1995–96 Supplement to the

Current Population Survey—0925–

0386—Reinstatement, no change—The

‘‘Tobacco Use’’ supplement to the

Current Population Survey conducted

by the Bureau of the Census will collect

data from the civilian noninstitutionalized population on smoking

status and prevalence, smoking

intervention dissemination, and changes

in smoking norms and attitudes. The

data will be used by the National Cancer

Institute to evaluate the effectiveness of

the American Stop Smoking

Intervention Study for Cancer

Prevention (ASSIST), a large scale

multi-state demonstration project.

Respondents: Individuals or

households; Number of Respondents:

200,000; Number of Responses per

Respondent: 1; Average Burden per

Response: .1169 hour; Estimated Total

Annual Burden: 23,380 hours. Send

comments to James Scanlon, Office of

the Assistant Secretary for Health, Room

737–F, Humphrey Building, 200

Independence Ave., SW., Washington,

DC 20201.

Written comments and

recommendations concerning the

proposed information collections

should be sent within 30 days of this

notice directly to the individual

designated.

Dated: March 21, 1995.

James Scanlon,

Director, Data Policy Staff, Office of the

Assistant Secretary for Health and PHS,

Reports Clearance Officer.

[FR Doc. 95–7308 Filed 3–23–95; 8:45 am]

BILLING CODE 4160–01–M

National Toxicology Program (NTP)

Public Meeting of the NTP Board of

Scientific Counselors’ Ad Hoc Working

Group To Review the Criteria for

Listing Substances in the Biennial

Report on Carcinogens (BRC)

A public meeting of the NTP Board of

Scientific Counselors’ ad hoc Working

Group to Review the Criteria for Listing

Substances in the Biennial Report on

Carcinogens (BRC), will be held on

April 24 & 25, 1995, in Washington, DC.

The meeting will be held at the

Washington Hilton and Towers Hotel,

1919 Connecticut Avenue NW.,

beginning at 9:00 a.m.

The purpose of the meeting is to

receive public comments on the criteria

for listing substances in the BRC, and to

review and make recommendations on

the criteria. The issues to be addressed

by this ad hoc group are (1) The

adequacy of existing criteria for listing

substances in future Reports; and (2) the

incorporation of mechanistic data as

part of the criteria for listing substances

in future Reports which may include the

consideration of sensitive sub-